Medical Therapy for Functional Mitral Regurgitation.
atrial fibrillation
mitral valve insufficiency
papillary muscles
stroke volume
ventricular remodeling
Journal
Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
pubmed:
22
7
2022
medline:
24
9
2022
entrez:
21
7
2022
Statut:
ppublish
Résumé
Functional mitral regurgitation (FMR) can be broadly categorized into 2 main groups: ventricular and atrial, which often coexist. The former is secondary to left ventricular remodeling usually in the setting of heart failure with reduced ejection fraction or less frequently due to ischemic papillary muscle remodeling. Atrial FMR develops due to atrial and annular dilatation related to atrial fibrillation/flutter or from increased atrial pressures in the setting of heart failure with preserved ejection fraction. Guideline-directed medical therapy is the first step and prevails as the mainstay in the treatment of FMR. In this review, we address the medical therapeutic options for FMR management and highlight a targeted approach for each FMR category. We further address important clinical and echocardiographic characteristics to aid in determining when medical therapy is expected to have a low yield and an appropriate window for effective interventional approaches exists.
Identifiants
pubmed: 35862021
doi: 10.1161/CIRCHEARTFAILURE.122.009689
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM